Learning Objectives:

  1. Identify the phenotype of cardiac amyloidosis in order to facilitate early diagnosis.
  2. Distinguish underlying causes of cardiac amyloidosis given differences in prevalence, genetics, prognosis and treatment.
  3. Enumerate emerging strategies to address TTR cardiac amyloidosis.
Session date: 
05/05/2023 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Mathew Maurer, MD